The Fund at Hula
50 Lakeside Ave, Burlington, VT, 05401, United States
Overview
THE FUND AT HULA IS A BUSINESS ACCELERATOR AND VENTURE CAPITAL FUND FOCUSED ON ELEVATING VERMONT. WE SUPPORT DARING ENTREPRENEURS, INNOVATIVE IDEAS, AND DISRUPTIVE TECHNOLOGY THROUGH SEED AND EARLY-STAGE FUNDING, MENTORSHIP, AND CONNECTIVITY. WE BELIEVE VERMONT IS THE IDEAL PLACE TO LIVE, WORK, AND PLAY... THAT IS WHY WE ARE STRIVING TO MAKE VERMONT THE IDEAL PLACE FOR GROWING BUSINESSES.
- Total investments
- 2
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 2
Sector focus
- Aerospace
- Biotechnology
- E-Commerce
- GreenTech
- Information Technology
- SaaS
- Software
Investment portfolio
- CoreMap
Participated · Series A · Feb 2022
CoreMap develops a proprietary electrophysiology mapping system that combines high-density electrical data acquisition with sophisticated analytical software to generate detailed electrical activation maps of atrial fibrillation. The platform is designed to help electrophysiologists identify arrhythmia sources more accurately during catheter ablation procedures. CoreMap plans to use the new capital to accelerate product development and move the technology closer to commercial availability. The company believes improved mapping can address persistent clinical challenges in AF treatment and support more targeted procedural decision-making. Founded in 2016 and headquartered in Burlington, Massachusetts, CoreMap is positioning itself to compete in the expanding electrophysiology market with strategic backing from Medtronic following the Series C financing.